|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01889 SANAI HEALTH GP
Nominal 
0.310 -0.010 (-3.125%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 85,217 | -30.206% | 122,098 | 175,923 | 67,608 | 121,404 |
| Cost of Sales | (68,353) | -21.355% | (86,913) | (84,248) | (27,053) | (90,483) |
| Gross Profit | 16,864 | -52.070% | 35,185 | 91,675 | 40,555 | 30,921 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | 2,517 | 341 | -- | -- | |
| Profit / (Loss) on Disposal | (124) | -- | -- | (2,484) | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (456) | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (12,939) | -- | 22,364 | 55,771 | 25,500 | 16,653 | |
| Taxation | (968) | -89.241% | (8,997) | (20,574) | (8,625) | (5,161) | |
| Profit / (Loss) from Discontinued Operations | 17,308 | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 1,491 | -71.686% | 5,266 | (5,980) | (7,850) | (5,070) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 4,892 | -73.746% | 18,633 | 29,217 | 9,025 | 6,422 | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,630 | 1.431% | 1,607 | 1,713 | (712) | (579) |
| Depreciation & Amortisation | 2,787 | -31.388% | 4,062 | 3,524 | 3,547 | 3,624 |
| Directors' Emoluments | 2,324 | 23.551% | 1,881 | 5,572 | 1,382 | 1,423 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Qualified | -- | Qualified | Qualified | Qualified | Qualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 3.370 | -76.791% | 14.520 | 23.750 | 7.250 | 5.250 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 2.499 | (0.458) | (0.013) | 0.000 |
| NBV per share ($) | 2.106 | -- | 2.059 | 1.921 | 1.622567 | 1.539626 |
| Remarks: | Real time quote last updated: 22/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 4,892,000 |
| %Change | -73.746% |
| EPS / (LPS) | RMB 0.034 |
| NBV Per Share (¥) | RMB 2.106 |